s6y BridgeBio Oncology Therapeutics, Inc. EFFECT

BridgeBio Oncology Therapeutics, Inc. EFFECT, filed Sep 10, 2026: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 10, 2026 4:30 P.M.
Form: S-3
CIK: 0001869105
Company Name: BridgeBio Oncology Therapeutics, Inc.
File Number: 333-298697